Regarding the role of adaptive immunity, it is notable that B2 M alone demonstrated some of the most consistent associations with all clinical outcomes and across disease cohorts, suggesting regulation of canonical antigen-presenting processes may be particularly relevant in dementia risk and/or prevention. The gene discussed is B2M; the disease is dementia.